Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8

Author:

Walle Thomas12345ORCID,Kraske Joscha A.16ORCID,Liao Boyu16,Lenoir Bénédicte78,Timke Carmen19ORCID,von Bohlen und Halbach Emilia2378,Tran Florian1011ORCID,Griebel Paul10ORCID,Albrecht Dorothee1ORCID,Ahmed Azaz278ORCID,Suarez-Carmona Meggy78ORCID,Jiménez-Sánchez Alejandro12ORCID,Beikert Tizian16,Tietz-Dahlfuß Alexandra1ORCID,Menevse Ayse Nur13ORCID,Schmidt Gabriele14,Brom Manuela14,Pahl Jens H. W.5,Antonopoulos Wiebke15,Miller Matthias5,Perez Ramon Lopez16ORCID,Bestvater Felix14,Giese Nathalia A.16,Beckhove Philipp13ORCID,Rosenstiel Philip10ORCID,Jäger Dirk2347,Strobel Oliver16,Pe’er Dana1712ORCID,Halama Niels234818,Debus Jürgen61920ORCID,Cerwenka Adelheid5ORCID,Huber Peter E.1620ORCID

Affiliation:

1. Department of Molecular and Radiooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

2. Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.

3. Department of Medical Oncology, University Hospital Heidelberg, Heidelberg, Germany.

4. German Cancer Consortium (DKTK), Heidelberg, Germany.

5. Department of Immunobiochemistry and MI3, Mannheim Institute for Innate Immunoscience, Heidelberg University, Medical Faculty Mannheim, Mannheim, Germany.

6. Department of Radiooncology and Radiotherapy, University Hospital Heidelberg, Heidelberg, Germany.

7. Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center, Heidelberg, Germany.

8. Department of Translational Immunotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.

9. Department of Radiation Oncology, St. Franziskus Hospital, Flensburg, Germany.

10. Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.

11. Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.

12. Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

13. Leibniz Institute for Immunotherapy, Division of Interventional Immunology, Regensburg, Germany.

14. Core Facility Light Microscopy, German Cancer Research Center (DKFZ), Heidelberg, Germany.

15. Institute of Pathology University Hospital Heidelberg, Heidelberg, Germany.

16. Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.

17. Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

18. Helmholtz Center for Translational Oncology (HITRON), Mainz, Germany.

19. Heidelberg Ion Therapy Center (HIT), Heidelberg, Germany.

20. Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany.

Abstract

Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune response involving a CXCL8/IL-8–dependent mechanism. In a randomized controlled pancreatic cancer trial, CXCL8 increased under radiotherapy, and NK cell positively correlated with prolonged overall survival. Accordingly, NK cells preferentially infiltrated irradiated pancreatic tumors and exhibited CD56dim-like cytotoxic transcriptomic states. In experimental models, NF-κB and mTOR orchestrated radiation-induced CXCL8 secretion from tumor cells with senescence features causing directional migration of CD56dimNK cells, thus linking senescence-associated CXCL8 release to innate immune surveillance of human tumors. Moreover, combined high-dose radiotherapy and adoptive NK cell transfer improved tumor control over monotherapies in xenografted mice, suggesting NK cells combined with radiotherapy as a rational cancer treatment strategy.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3